Kovai Medical Center & Hospital Ltd
NSE: KOVAI BSE: 523323Healthcare
Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]
₹5,384
52W: ₹5010 — ₹6725
PE 25 · Book ₹1088 · +395% vs bookMarket Cap₹5,890 Cr
Stock P/E25Price to Earnings
ROCE23.3%Return on Capital
ROE21.2%Return on Equity
Div. Yield0.18%Face Value ₹10
Shareholding Pattern
Promoters56.53%
FIIs1.21%
DIIs4.47%
Public37.8%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 56.5% | 56.51%▲0.0 | 56.55%▲0.0 | 56.55% | 56.55% | 56.52%▼0.0 | 56.53%▲0.0 | 56.53% |
| FIIs | 0.32% | 0.44%▲0.1 | 0.55%▲0.1 | 1.1%▲0.6 | 1.27%▲0.2 | 1.25%▼0.0 | 1.31%▲0.1 | 1.21%▼0.1 |
| DIIs | 4.28% | 4.37%▲0.1 | 4.43%▲0.1 | 4.03%▼0.4 | 4.52%▲0.5 | 4.89%▲0.4 | 4.73%▼0.2 | 4.47%▼0.3 |
| Public | 38.91% | 38.67%▼0.2 | 38.46%▼0.2 | 38.32%▼0.1 | 37.65%▼0.7 | 37.34%▼0.3 | 37.43%▲0.1 | 37.8%▲0.4 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 303 | 321 | 321 | 315 | 344 | 355 | 357 | 374 | 392 | 407 |
| Expenses | 217 | 225 | 229 | 229 | 248 | 252 | 256 | 268 | 285 | 291 |
| Operating Profit | 85 | 96 | 92 | 86 | 96 | 103 | 101 | 106 | 107 | 116 |
| OPM % | 28% | 30% | 29% | 27% | 28% | 29% | 28% | 28% | 27% | 28% |
| Net Profit | 43 | 53 | 52 | 46 | 51 | 58 | 55 | 57 | 59 | 65 |
| EPS ₹ | 39.67 | 48.53 | 47.69 | 41.81 | 46.32 | 52.82 | 49.99 | 52.3 | 53.79 | 59.42 |
AI Insights
Revenue Trend
TTM revenue at ₹1,530Cr, up 11.6% YoY. OPM at 28%.
Debt Position
Borrowings at ₹399Cr. Debt-to-equity ratio: 0.34x. Healthy balance sheet.
Capex Cycle
CWIP at ₹224Cr (17% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 4.47% (+2.28pp change). FIIs: 1.21% (-0.99pp change). Promoters hold 56.53%.
Margin & Efficiency
ROCE improving from 21% (Mar 2014) to 23% (Mar 2025). Working capital days: -57.
Valuation
PE 25x with 23.3% ROCE. Price is 395% above book value of ₹1,088. Dividend yield: 0.18%.
Recent Announcements
- Intimation Under Regulation 30 Of SEBI(LODR) Regulations,2015 11 May - Board approved slump sale of AHS division to Dr NGP Trust for Rs.84.54 lakh, by 30 Nov 2026.
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 11.05.2026 11 May - Board approved slump sale of AHS courses division to Dr NGP Trust for Rs.84.54 lakh; completion by Nov 2026.
- Board Meeting Intimation for Considering The Audited Financials Results Of The Company For The Quarter / Year Ended 31St March, 2026. 25 Apr - Board meeting on 22 May 2026 to consider audited Q4/FY26 financial results; trading window remains closed.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Apr - We enclose the copies of Newspaper Advertisement published in English and Tamil in the Trinity Mirror and Makkal kural respectively, with regard to the Special …
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 13 Apr
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse